P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)

• Armin Ghobadi,
• Ibrahim Aldoss,
• Shannon Maude,
• Alan S Wayne,
• Deepa Bhojwani,
• Ashish Bajel,
• Bhagirathbhai Dholaria,
• Rawan Faramand,
• Ryan Mattison,
• Michael Rettig,
• Ouiam Bakkacha,
• John Muth,
• Angela Pannunzio,
• Brett Ramsey,
• Eileen Mcnulty,
• Matthew Cooper,
• Jan Davidson-Moncada,
• Kenneth Jacobs,
• John Dipersio

Affiliations

Armin Ghobadi

1 Washington University School of Medicine, St. Louis, United States

Ibrahim Aldoss

2 City of Hope, Duarte, United States

Shannon Maude

3 Children’s Hospital of Philadelphia, Philadelphia, United States

Alan S Wayne

4 Children’s Hospital Los Angeles, Los Angeles, United States

Deepa Bhojwani

4 Children’s Hospital Los Angeles, Los Angeles, United States

Ashish Bajel

5 Peter Mac Callum Cancer Institute, Melbourne, Australia

Bhagirathbhai Dholaria

6 Vanderbilt University Medical Center

Rawan Faramand

7 Moffitt Cancer Center, Tampa, United States

Ryan Mattison

8 University of Wisconsin, Madison, United States

Michael Rettig

1 Washington University School of Medicine, St. Louis, United States

Ouiam Bakkacha

9 Wugen, St. Louis, United States

John Muth

9 Wugen, St. Louis, United States

Angela Pannunzio

9 Wugen, St. Louis, United States

Brett Ramsey

9 Wugen, St. Louis, United States

Eileen Mcnulty

9 Wugen, St. Louis, United States

Matthew Cooper

9 Wugen, St. Louis, United States

Jan Davidson-Moncada

9 Wugen, St. Louis, United States

Kenneth Jacobs

9 Wugen, St. Louis, United States

John Dipersio

1 Washington University School of Medicine, St. Louis, United States